Open access peer-reviewed chapter

Antimicrobial Resistance Leading to Develop Livestock-Associated Methicillin-Resistant S. aureus, and Its Impact on Human, Animal, and Environment

Written By

Muhammad Farooq, Ifra Siddique and Zia Ullah

Submitted: 28 December 2020 Reviewed: 27 August 2021 Published: 08 December 2021

DOI: 10.5772/intechopen.100169

From the Edited Volume

Insights Into Drug Resistance in Staphylococcus aureus

Edited by Amjad Aqib

Chapter metrics overview

191 Chapter Downloads

View Full Metrics


The most important microbe in humans is Staphylococcus aureus, which has caused worldwide dispersion in both nosocomial and community settings. The impact of Gram-positive Staphylococcus Aureuson the host is extremely detrimental to illness development. The life form is noteworthy for its ability to receive anti-toxin protection from a variety of anti-toxin classes. The development and distribution of methicillin-resistant Staphylococcus Aureus (MRSA) strains, which are generally multi-drug resistant in clinics and, as a result, in the population, cause severe mortality and bleakness. The research of MRSA illness transmission has advanced since its underlying event, which necessitates a complete clinical approach to dealing with take on this microorganism. For long term use drug of choice is vancomycine nevertheless its efficacy has been put to the test by rise in opposition. More modern anti-MRSA anti-infection medicines have been approved for clinical usage in the last 10 years or so. The aim of this chapter is to offer related data on the genus Staphylococcus and the evolution of antibiotic resistance in addition a discussion of the most important antibiotic resistance mechanisms. Although they are notorious for causing anti-infection blockage, there is a constant need for exploring innovative MRSA antagonists from various sources, including plants, and assessing non-anti-toxin draws close.


  • antibiotics
  • staphylococci
  • MRSA
  • environment
  • livestock infection

1. Introduction

Staphylococci are most seen in humans and other animals. They were usually separated into two groups based on their size to collect blood plasma. The most pathogenic species, S. aureus, is established by coagulase-positive staphylococci. There are currently over 30 distinct types of coagulase-negative staphylococci (CNS). CNS constant skin commensals, even though a few animal species can produce adulterations. It is now evident that the separation of staphylococci into positive and negative strains is unnatural and, at times, misleading. Coagulation is a marker for S. aureus; however, there is no immediate confirmation that it is a virulence factor [1]. Similarly, several of S. aureus’s distinctive secludes are defective in it. In any event, the span is still widely used by clinical microbiologists. Some of it binds to protein and polysaccharides, which are linked to virulence. The combined effect of various factors transmitted during illness causes harm [2]. Antibodies for staphylococcal toxins and compounds neutralize them; however, vaccines are not available. Antimicrobial therapy and clinical drainage are commonly required to treat blisters, massive bubbles, and looping illnesses. These are difficult to treat with anti-toxins alone and frequently necessitate the removal of the device. A rare strain in which hospitalized patients are resistant to the maximal usage of antibiotics for contaminations, vancomycin is the final medicine to which opposition has not been produced [3].


2. Strains of S. aureus

Although S. aureus is normally a commensal part of the human microbiota, its role sometime as opportunistic pathogen, which causes several diseases in skin as abscesses, sinusitis as respiratory diseases, and food poisoning. Pathogenic strains regularly promote infections by causing virulence causes including strong protein toxins and the creation of a cell-surface protein that attaches to and deactivates antibodies. The enhancement of antibiotic-resistant types of Staphylococcus aureus, such as methicillin-resistant Staphylococcus aureus (MRSA), is a worldwide scientific problem. Even though there are wide investigation and expansion, no S. aureus vaccine has been approved. There are now 32 species and the genus Staphylococcus has eight subspecies, numerous of which specially inhabit the human body, although Staphylococcus aureus and Staphylococcus epidermidis are the two most explained and examined strains.


3. Staphylococcal infections in humans

S. aureus disease are normally pyogenic and severe, and if not treated, they can disperse to neighboring tissue or metastatic sites via bacteremia [2]. Several common diseases caused by S. aureus include furuncles or boils, cellulitis, impetigo, and post-operative wound diseases in several sites. S. aureus causes several skin and soft tissue disorders, including mastitis. Staphylococcal mastitis has received less attention than S. aureus suppurations in humans. According to estimates, 1–3% of nursing mothers suffer with mastitis. Infection usually appears two to three days after birth, with symptoms ranging from abscess formation to cellulitis development [4]. In extreme cases, general signs such as a common cold and fever may arise.

Toxic shock syndrome (TSS), and staphylococcal food poisoning are examples of staphylococcal diseases produced exclusively by the production of staphylococcal toxins. Enterotoxins are resistant to heat and may live circumstances that would normally destroy bacteria [5]. Furthermore, enterotoxins are resistant to the action of proteolytic enzymes and can remain active in the digestive tract after consumption [6, 7]. After consuming toxic food, nausea and vomiting ensue, and the incubation period is brief. Possible adverse effects include diarrhea, hypotension, and dehydration. Enterotoxin production has been found in S. xylos, S. chromogenes, S. cohnii, S. pseudintermedius, epidermidis, S. lentus, S. lugdunensis, S. sciuri, S. saprophyticus, S. warneri, and S. hyicus, among others [3, 6]. Approximately partial of the CNS species found to be involved for human diseases, particularly S. epidermidis, are often accountable for nosocomial and suppurative infections linked with prosthetic devices [8, 9]. The increased suppuration rate is related to the bacterium’s ability to produce an extracellular polysaccharide. The development of the protective advantages and biofilms on bacteria is discussed in further detail below.

Joint infections, septicemia, urinary tract infections, peritonitis, infections, wound infections, and endocarditis are the second most common CNS conditions associated with human suppuration. Staphylococcus saprophyticus, another opportunistic bacterium, causes urinary tract infections in humans [2, 10].

As novel zoonotic pathogens, S. lugdunensis and S. schleferi identified. Staphylococcus lugdunensis, another human pathogen, has lately emerged as animal pathogen involved in respirational and skin diseases. It has previously been linked to skin infections as well as invasive diseases including osteomyelitis, endocarditis, and sepsis. Staphylococcus schleiferi, formerly related to skin infections in dogs, has recently been linked to human metastatic infection, endocarditis, and endophthalmitis [11, 12].


4. Staphylococcal infections in animals

The only bacteria that cause significant disease in animals are Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus hyicus, and Staphylococcus pseudintermedius. Other Staphylococcus species exist primarily correlated with devious animal infections. S. aureus produces septic arthritis in hens, as well as subcutaneous abscesses. S. aureus is a common cause of dermatitis in goats and sheep, and it can cause botryomycosis in horses and pigs, a persistent, suppurative granulomatous illness. S. aureus, like S. pseudintermedius, causes suppurative illnesses in companion animals. Staphylococcus hyicus causes exudative epidermitis, called as greasy pig sickness. In several countries, methicillin-resistant S. pseudintermedius is becoming a significant clinical issue in veterinary medicine [13].

Intramammary infection causes in different animals: Even though bovine IMIs are the most economically significant, staphylococci IMIs can generate substantial losses in locations where sheep and goats are raised for milk. Similarly, substantial financial losses have been reported in places where buffalo or camel milk is generated because of mastitis. Due to IMI problem, financial loss occurs in different ways—rejection of milk because of its poor quality or milk withdrawal after or before medication, high treatment fees, high labor cost all these include [12, 14]. Aside from the apparent economic losses caused by IMIs, there are sum of indirect expenditures that are difficult to measure. Subclinical diseases in a herd usually go undiagnosed, causing in a steady drop in milk supply and a reduction in total milk value. This results in a consistent loss of income surplus, even when found, can take a considerable amount money and time to cure [9].

This species S. aureus is possibly the most well-known mastitis pathogen because once infection occurs due to this species, its unable to treat and become persistent [15].


5. Structure

5.1 Taxonomy

RNA hybridization, ribosomal DNA (r-RNA), and approximately 16 oligonucleotide r-RNA analyses also reveal that Staphylococci compile family level infidelity. This social problem occurred in a wide group of Bacillus-Lactobacillus-Streptococcus, which described Gram-positive bacteria with low G + C DNA components. In any event, Biochemica discovered 30 different kinds of staphylococci [3, 16].

Eleven of these may be secured with individuals such as guests. S. aureus (nares) and S. epidermidis (nares, skin) are fundamental visitors with the highest pathogenic potential. S. saprophyticus (skin, occasionally) is another common cause of urine plot contamination. S. hemolyticus, S. simulans, S. cohnii, and S. warter are all bacteria. Furthermore, S. lugdunensis can cause illness in people [6].

5.2 Morphology

Gram-positive cells are found in S. aureus cells and appear to be in good health. When seen via a light magnifying device, they are frequently in bunches that resemble grapes after staining. The Greek name for these bacteria is ‘Staphylococcus,’ which means “in the shape of (staphyle) grapes packed with berry (kokkos)” [17]. Filtering electron small perception reveals primarily circular shaped cells with smooth surfaces [18]. The width of the cells ranges from 0.5 to 1.0 M [19]. On electron microscopy, a thick cell divider may be seen, as well as an obvious and shapeless cytoplasmic layer and shapeless cytoplasm [20].

5.3 Isolation and identification

The existence of staphylococci in a real-world problem can be linked from the start following testing with a second Gram stain. In any event, little amounts of microorganisms in blood obstruct minute examination and must be improved from the outset. Striking raw material from the clinical model into strong medium, such as different agar including blood, tryptic soy, or heart implantation, separates living things. Models that are at risk of being harmed by different bacteria can grow on mannitol salt agar containing 7.5% sodium chloride, which allows crown indulgent staphylococci to grow [21]. In an ideal world, a Gram stain of the solution would be done, as well as tests for catalase and coagulase production, allowing the coagulase-positive S. aureus to be identified quickly. The creation of thermostable deoxyribonuclease is another enormous test for S. aureus. Testing conditions might need S. aureus to agglutinate with latex particles, coated with immunoglobulin G and fibrinogen, which bind protein and the batching factor autonomously on the bacterial cell surface [5, 22, 23, 24]. These are available from business sources (e.g., Staphaurex). The most recent latex test (Pastaurex) uses monoclonal antibodies against serotype 5 and 8 capsular polysaccharides to reduce the number of false negatives. (Some novel clinical isolates of S. aureus necessitate the production of coagulase in the same way that packaging factors do, which can make checking tedious.) The association of S. epidermidis (and, to a lesser extent, other coagulase-negative staphylococci) with no so-called comial illnesses associated with possessing gadgets suggests that partition of these microorganisms from blood will undoubtedly be significant, especially if reformist blood social orders are positive. Nowadays, S. epidermidis and other types of Staphylococci are identified using commercial biotype ID units such as as API Staph Ident, API Staph-Trac, Vitek GPI Card, and Micro breadth Pos Combo. Preformed strips containing test substrates are among them [20, 25].

5.4 S. aureus infection pathogenesis

S. aureus communicates several cell surface-related and extracellular proteins that are potentially toxic. Pathogenesis is complex for most diseases caused by this living creature. Along these lines, it is difficult to properly determine the role of some random element. This also reflects the shortcomings of many animal models for staphylococcal diseases. In any event, linkages between strains unrelated to specific illnesses and articulation of specific variables suggest their importance in pathogenesis. In the case of some toxins, symptoms of human illness may be replicated in animals with pure proteins [26]. The use of atomic physics has resulted in late progress in the understanding of the pathophysiology of staphylococcal diseases. Potentially hazardous components have been cloned and sequenced, and proteins have been screened. This has sparked atomic-level research into their modes of action, both in vitro and in model frameworks. Furthermore, characteristics encoding potential harmfulness factors have been deactivated, and the destructiveness of the mutants in creature models has been compared to the wild-type strain. Any reduction in harmfulness traps the missing component. If destructiveness is reinstated when the quality is returned to the freak, then “Sub-atomic Koch’s Postulates” have been satisfied. This approach has confirmed a couple of S. aureus’s damaging components [23, 27].


6. Infection in the general population

S. aureus is responsible for a wide range of contaminations in humans. Clinical illnesses caused by S. aureus, square measure divided into native space and health facility categories based on the onset of illness. These two strains square measure apparent in clinical indicators of contamination, anti-infection quality, and therefore the genetic basis of the contaminating S. aureus strains [21]. For a long period, S. aureus has been primarily a health care organism, and it may be a major source of mortality and dullness in medical clinics. Regardless, the native space S. aureus illnesses are increasing in square measure. Many clinical bacteriemia, infective carditis, skin and sensitive tissue contaminations, osteoarticular disorders, and pleuropulmonary contaminations are all caused by S. aureus. Other clinical contaminations include epidural sore, meningitis, dangerous shock situation, and urinary plot infections. According to European research, the prevalence of osteoarticular infections in children ranges from 7 to 22 per 100,000 person-years. In males, its ratio is more as compared to female as result of children in France are 24 per 100,000 for boys and for girls its ratio is 19 per 100,000 per year. Some ethnic groups may be more vulnerable, with Maori and Pacific Islander people overrepresented in a New Zealand study of 813 instances of acute OM. Since 2000, CA-MRSA has become a far more common cause of acute osteoarticular infections in the United States. In a study of 158 cases in Tennessee, the proportion of osteoarticular infections caused by CA-MRSA increased from 4 to 40% between 2000 and 2004. Similarly, in Dallas, TX, the proportion of cases of acute OM caused by CA-MRSA was 6% from 1999 to 2001 and 31% from 2001 to 2003. Between 2001 and 2010, 195 of 376 (52%) cases of S. aureus OM in Houston, TX, were caused by MRSA. S. aureus produces a wide range of SSTIs, from the benign (e.g., impetigo and simple cellulitis) to the potentially fatal. It is the most often isolated pathogen from surgical site infections (SSIs), cutaneous abscesses, and purulent cellulitis. We discuss the epidemiology, pathogenesis, clinical characteristics, and the management of S. aureus SSTIs, with a focus on the recent community-associated MRSA pandemic (CA-MRSA) [28].


7. Factors that cause harm

S. aureus has complete control over the harmfulness variables. Components enable live beings to function as microorganisms, which cause a wide range of animal contaminations, including human contamination. Destructive factors aid in the connection of cells, the separation of the host’s resistant shield, tissue infiltration, the cause of sepsis, and the inspiration of poison interceded circumstances. This is the cause of persistent staphylococcal infections in the absence of a strong host immune response [8].


8. The study of disease transmission

8.1 Nasal carriage

S. aureus is a commensal bacterium that acts as a leader. The natural claim to fame of the head is the front nares, where the animal colonizes in individuals. S. aureus nasal carriage increases the risk of infection, particularly in health care settings [29]. S. aureus nasal carriage may affect up to 30% of humans [30]. Because nasal carriage enhances the chance of the advancement of cautious site, lower respiratory, and flow framework diseases in health care facilities, attempts are being performed to eliminate the carriage utilizing diverse methodologies [11, 12].

8.2 Rise and advancement of MRSA

S. aureus is a commensal bacterium that is also a pioneer. Front Nares is a particular head of the environment in which animals invade people. Nasal S. aureus heightens the disease’s risk, particularly in clinical settings [29]. S. aureus can reach 30% of the human population by normal nasal transportation [30]. Because nostrils enhance the danger of careful location, decreasing illness, and circulation of respiratory systems in medical clinics, attempts are being made to publish it.

Sarman is a strain of S. aureus that transmits the MECA quality, which encodes penicillin proteins that restrict extras, PBP2A. Anti-microbial beta-lactams work by inactivating penicillin-limiting proteins (PBP), which is a critical accelerator for the conjunction of bacterial cell dividers. In all situations, this anti-infective drug has only a modest affinity for PBP2A; nonetheless, this chemistry escapes inactivation and is part of the essential PBP involving the integration of cell dividers and bacteria, even in the presence of beta-lactam anti-microbes. Sarman is resistant to most beta-lactam anti-infection drugs because of the presence of MECA [15]. Penicillin was discovered in 1928 as an anti-toxin primary beta-lactam and was found to captivate weapons against S. aureus infection. There were instances of S. aureus tension that resisted penicillin in the 1940s, which was faster following the presentation in the institution [7]. This stress caused Beta-lactamase plasmid beta-lactamase (penicillinase) to be produced, which breaks beta-lactam penicillin rings, resulting in non-active anti-microbes [31, 32]. In the 1950s, penicillin resistance was restricted to the closure of the S. aureus emergency clinic. In the late 1960s, due to the mobility of plasmid quality penicillin (Blaz) and diffusion of clones from safe strains, more than 80% of S. aureus was captivated, independent of area and the establishment of an emergency clinic, was extremely resistant to penicillin [9, 33]. The researchers then examined methicillin, a semi-designed penicillin that was resistant to enzymatic corruption from penisination, in S. aureus with opposition penicillinase intervention. Methicillin was introduced to the center in 1961; however, after one year, S. aureus blockage restricts the use of methicillin (MRSA) [34]. For the next 10 years and beyond, the MRSA outbreak is projected in many regions of the world, particularly in European nations [35, 36]. The Sarman appears in the form of a supported microbiological clinic, and the major components of these reports are from an emergency clinic. In 1981, the Battle-Lactam anti-infection protection system in the Sarjor separator was described [4]. As previously stated, MRSA Supegate provided a high-quality MEC code for PBP2A. Quality is a variable genetic component ranging from 21 to 60 KB known as a Meca ribbon (SCMCECA) from the chromosome (SCMCECA). Two ideas describe the origins of MRSA. The specific clone idea proposes that the adaptable hereditary components join the S. aureus popula at an event and bring a specific MRSA clone framework, which disseminated all over the globe. Other most common theory is that MRSA is created by how many times the process of exchanging portable hereditary components becomes phylogenetic, including S. aureus (MSSA) strains (MSSA) [MSSA] [9, 32, 33, 34, 35]. Related Medical Care and Local Sarma Area

8.3 Medical care related to MRSA (HA-MARM)

SRSA in medical therapy (HA-MRASA) is S. aureus collected from patients at least two days after in hospital or with the danger of Sarma (history of hospital today, medical procedures, dialysis, or homes at the Advisory Office are drawn in one year earlier). The existence of a catheter that is directly eternal clinic or percutaneous gadgets (such as tracheotomy tubes, gastrostomy cylinders, or Foley catheters) with Cultural Clock. Alternatively, on the other side of MRSA termination [4, 36], MRSA for local regions (Ca-Mrasa) occurs when S. aureus discharges patients after 2 days in hospital and without the previously described MRSA danger concerns. MRSA was previously and resistant to non-beta lactam anti-infection agent until the 1990s.

8.4 Health care-associated MRSA

MRSA has traditionally been thought of as a clinic- or health care-related pathogen (HA-MRSA), affecting those patients by doing surgery or some medical devices implants and as well as those who are immunocompromised. Health care-related MRSA strains are often multidrug resistant and contain SCCmec types I, II, and III [37]. Most HA-MRSA types worldwide are CC5, CC8, CC22, CC30, and CC45 [28, 37].


9. Resistance of staphylococci to antimicrobial drugs

Clinic strains of S. aureus often impervious to various anti-infection agents. Without a doubt, strains are impervious to all clinical medications, paying little attention to vancomycin and teicoplanin glycopeptides, it has been clarified [38]. The term MRSA reference methicillin obstruction and most of the methicillin strains likewise increase. Plasmid-aniseed vancomycin opposition has been distinguished in a few Enterococci and the obstruction determinant has been moved from Enterococci to S. aureus in the lab and can happen normally [23]. S. epidermidis nosocomial secludes sturdy to a few anti-toxins including methicillin. Notwithstanding, S. aureus expresses protection from disinfectant and affection, for example, the quartier ammonium compound, which can help its endurance in the medical clinic climate. Since the start of the anti-microbial time, S. aureus has reacted to the presentation of new medications by securing quickly with an assortment of hereditary instruments including (1) plasmid extraction some procurement or extra data in chromosomes through transposon or DNA inclusion type and (2) with a chromosomal quality change [5].

Many determinants-encoded plasmids are recently put into chromosomes on sites related to the determinant of the methicillin resistance. There may be benefits for organisms that have a determinant of resistance in the genetic material due to more stability. The four basic mechanism of resistance to bacteria are as follows: (1) enzymatic deactivation of drugs, (2) changes to target area of the drug to prevent binding, (3) enhanced drug efflux to avoid toxic absorptions collects in cells, and (4) permit mechanisms in which an analytical resistant type is stated [10, 11, 38].

9.1 Antimicrobial drugs

Penicillin first time in S. aureus showed exceptional adaptability. The impediment has resulted in tone prescriptions in a short period of time. A few strains are now resistant to the most used anti-microbials. He is concerned that no new anti-infection drugs are on the horizon. Every new advancement may be traced back to an existing medication [5, 34].

The initial approach used by the pharmacological production to identify antimicrobial medicines is to channel organic products and designed synthetic compounds for antibacterial activity. After that, the activity instrument is considered. Another technique for determining the antimicrobial age has been obtained. The likely aims, for example, chemicals, are up to the major capacities (e.g. in cell division) are recognized based on microbial and metabolic physiology information. The identification approach is then refined to differentiate some objective atomic inhibitors. Similarly, given specific atomic knowledge on the target particles, precise inhibitors may be devised [22].

9.1.1 Mechanism of methicillin resistance in staphylococci

Methicillin resistance develops because of the mecA gene being acquired, which determines a complementary penicillin-binding protein, with a poor attraction for -lactam antibiotics [37], Despite of inactivation of cells’ natural penicillin-binding protein, the production of PBP2a allows bacterial cell wall production to continue in the existence of lactam antibiotics. Cephalosporins and cefamycins have resistant to lactam antibiotics, which are conferred via the mecA gene.

The mecA gene is part of the Staphylococcal Cassette Chromosome mec (SCCmec), a large mobile genetic element [19, 39].

International classification of Staphylococcal types of chromosome elements now contains 11 kinds of different SCCmec elements. Mec gene is protected by this Staphylococcal chromosomal which has been found in CPS and CNS [10]. In CNS, the structure of SCCmec elements is polymorphous with abundant amount of CCRmec sequences found, but not used for MRSA [40]. For the development of novel MRSA, clones’ greater frequency and diversity of SCCmec elements required that play a vital role in CNS and CNS is reservoir of mec elements. Horizontal transfer of SCCmec elements to S. aureus from CNS is still not found [38]. For many years, scientists have speculated about the origin of the mecA gene. mecA gene homologous have been discovered in S. sciuri and S. vitulinus, neither instance is the mecA gene present in a mecA complex like SCCmec [22]. Two scientists named as Tsubakishita and colleagues discovered a mecA gene similar in S. fleuretti that had almost 100% sequence with MRSA strain N315 and resided on a structure that was nearly matching to the mecA complex. Staphylococcus fleuretti is a commensal bacterium that belongs to the S. sciuri group of staphylococci [18]. Direct detection of methicillin resistance gene in staphylo which lives in animals serves as reservoir for making new SCCmec elements [20].

Molecular research on a S. A new mecA homolog was discovered after a methicillin-resistant S. aureus strain was reported to be phenotypically resistant to methicillin but on other hand when tested with polymerase chain reaction (PCR) assay it was negative [1]. The bacterial strain in which the gene was originally sequenced, S. aureusLGA251, shares 70% nucleotide similarity with the conventional mecA gene [23]. The investigation of Garca-lvarez and colleagues revealed that mecALGA251 was discovered in S. aureus lineages commonly linked with cattle, such as clonal complex (CC)130, CC1943, and sequence type (ST)425, implying the presence of a zoonotic MRSA reservoir. Furthermore, evidence of mecALGA251-carrying MRSA strains being transmitted from animal to human has been observed [30]. The IWCC renamed the mecA variant mecC [41] in 2012. The mecC gene is located on a new SCCmec element known as SCCmec XI [14]. S. methicillin-resistant S. aureus strains with the mecC gene have been proven to cause a variety of illnesses in people, and they appear to be mostly community associated.

9.2 One health and antibiotic resistance

One well-being concept reveals that human well-being is inextricably linked to the environment and its inhabitants. Because the well-being of animals, people, and the environment are all intertwined, interdisciplinary approaches to advancing the strength of each of these areas are required. As the human population grows, more people come into touch with animals, increasing the risk of disease transmission between humans and larger animals. The concept of one’s well-being is quite related to the idea of environmental change and global travel risks. The achievements of Robert Koch, Rodolph Virchow, and William Osler in the development of vaccinations and their impact on human health, the management of zoonosis, and germ theory formed the framework of one health [25] (Figure 1).

Figure 1.

How antibiotics spreads.

9.3 New resistance variants continue to emerge

With a Gram-positive entrance to multi-fiditive Gram-negative microscopic organisms, which is a limited or completely less handling option, large variations in the degree of opposing predominance occur. Some attention has been drawn to the quality that encodes the novel metallo-lactamase 1 (NDM-1) (NDM-1) (NDM-1) which renders Gram-negative enterobacteria resistant to the line’s most recent anti-toxins, such as Carpenem [10]. Indeed, this is an AMR concern since there has been an overall increase in the risk of delivering enterobacteria in Europe and throughout the world as to most carpenemase characteristics. Another issue that has emerged in the last decade is multi- or enlarged TB, Neisseria (microorganisms causing gonorrhea) that is resistant to the most current cephalosporins, and problematic clostridium that causes a severe moxifloxacin safe flat mate. Regardless, progress has been made in comprehending the unpredictable nature of opposing reversibility [40]. The investigation discovered that there was a minimal or no risk of AMR reversals after being defined in Community and non-Community situations [37, 38].

9.3.1 Antibiotic-resistant bacteria transmission

The emergence of multi-obstruction detonates, particularly among Gram-negative bacteria, has drawn attention to the growing relevance of genetic component coding transfer for multi-resistance, as well as the potential zoonotic transmission (creature based). The term “resistome” represents new information regarding the transmission of AMR bacteria [22]. Resistments are a group of characteristics that were first discovered in terrestrial microscopic organisms. It is necessary to be accountable for the development of various defense mechanisms that allow soil microorganisms to survive in the face of anti-microbials found naturally in the environment. It is considered that attributes from blockage might perhaps be transferred to non-land microscopic creatures, therefore exacerbating opposition difficulties. Regardless of whether it is debated, research reveals that some safe microorganisms have been more successful in sustaining extensively and enduringly owing to the resistome [23]. Antimicrobial misuses outside of human medicine is an additional aggravating element in AMR, notably the development of AMR in animals and humans [14, 24, 41]. The use of antimicrobials in agriculture can provide a large source of antimicrobial safe microscopic organisms that can spread to people through food supply when critters are eaten. This includes non-therapeutic applications, such as development progression. This also includes using it as a prophylactic to try to prevent illnesses from developing in food species and as a useful specialist to cure debilitated creatures. See the previous section. Farming serves as a reservoir for AMR microorganism transfer to and from humans [13]. However, it remains difficult to correlate the anti-microbial inhibition of food default microorganisms, the use of anti-toxins in agriculture, and the clinical confinement of human safe bacteria. That is, environmental connections between individuals and dynamic farming to increase the frequency of illnesses in certain years may be corresponding to develop the usage of anti-toxins that may potentially choose safe microscopic organisms. It was proven in 1976, that someone may follow E. coli who was protected from poultry in the experimental horticulture plot to human ranchers nearby [29]. Recently, it was possible to track links between two ranchers in Denmark, both of whom had MRSA infection. Furthermore, animals were on their 28-mile-distance farmstead. More specifically, a rancher who maintained two horses and two cows was found to have MRSA blood infection. Others have a portion of 10 sheep and ranchers had MRSA-infected wounds [39, 42]; when their case was discovered, they were identified as another MRSA strain that had been accounted for in steers and Danish analysts went out to examine animals on the two homesteads. One cow on one ranch and three sheep on other farms spread new strains. All bacterial samples from the house and the two persons are identical in a few tests and have a similar resistance design; that is, they are defenseless to anti-infection drugs that are not beta lactams (penicillin and cephalosporin). Then, all genomes were sequenced (which was unthinkable in 1976) and compared to how near all instances were. Detaches from ranchers and steers tests are nearly identical (five SNPs), as are disengages from various ranchers and most sheep. There is a difference of 154 SNPs in all instances (single-nucleotide polymorphism—single letter update on 2004 back paper, BP 6.1 antimicrobial opposition 6.1–9 “duplicating mistake” in hereditary code). Because of their relationship, the example created bunches based on two domesticated animals: first, ranchers and cows, and second, ranchers and sheep [43]. Following that, phylogenetic analysis uncovers two distinct gatherings explicitly for horticulture comprising of human cases and their own domesticated animals, while human confines and creatures from a similar farming are distinct with only a few SNP, implying the possibility of zoonotic transmission. Another study recognizes numerous characteristics and changes that are associated with host and harmfulness communications, and that this detach MECC-Mrasa CC130 is occasionally seen in humans. They are said to have been dispatched among animals and mankind [38, 44]. Nonetheless, the examination of this type of proof still has components. This has not been detected before, and the example size is small. It is possible that all hereditary varieties of secludes on specific farming can address the presentation of the two MRSA in the group, rather than a presentation followed by organization. If this happens, the transfer of monster beings can be like zoonosis. “Different hosts” of CCC CC130 MRSA include cows and sheep, as well as ponies, rabbits, felines, canines, deer, canines, mice, and wild avian animals. Examination has clearly supported the notion that sophisticated civilization has increased the possibility of safe microorganisms propagating and thriving in all animals and human surroundings [39, 45]. According to this perspective, as the value of the dollar rises, so will the risk of AMR and, as a result, the necessity to develop new antimicrobial products.


10. Preventive approaches to control S. aureus

There is currently no vaccination available to fight carrier diseases. There may also be reasons to investigate illness prevention strategies, particularly in hospitalized patients. Human volunteer hyperimmune whey donors or modest monoclonal antibodies directed at surface-components, such as rules for capsular adherence of proteins or proteins from the surface, can also impede bacterial compliance in Dan, increasing cell phagocytosis. In fact, a vaccine prototype based on S. aureus capsular polysaccharide has been developed.

Clinical infections caused by S. aureus are expected to remain frequent and severe. Not only have there been waves of growing antibiotic resistance, but the clinical illness spectrum is also changing. We have seen two distinct shifts in the epidemiology of S. aureus infections over the last two decades: first, an increase in the number of health care-associated infections, particularly IE and prosthetic device infections, and second, an epidemic of community-associated SSTIs caused by strains with specific virulence factors. There is little question that the landscape of host-pathogen interactions will continue to alter in the next decades [40].

11. Conclusion

S. aureus and many more are very dangerous for human as animals. They caused several diseases in them especially, respiratory problem and others which are described the chapter in brief. Now, some drugs and vaccine should be made to control it as most of the species is untreated and cannot be eradicated. Sulfonamide, penicillin, and streptomycin are used to test antimicrobial time. The assurances of these specialists in terms of feasible control of a broad range of bacterial illnesses are typically filled up with a plethora of antibacterial specialists presently available. As of today, it is difficult to imagine the fear and stress connected with the recurrence of previous severe illnesses. Is it possible to grasp anti-infection resistance, or are we returning to our inability to cope with harmful microorganisms? There is no legitimate explanation for fear. Although most bacterial illnesses can be easily treated, there are a few of actual difficulties that are not far away.


Muhammad Farooq has written the main chapter, Mr. Zia Ullah has helped in design, and Ifra Siddique has made final transcript.

Conflict of interest

“The authors declare no conflict of interest.”


  1. 1. Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiological Reviews. 1991;55:733
  2. 2. Wilkinson BJ, Easmon CSF, Adlam C. Staphylococci and Staphylococcal Infections. Staphylococci and Staphylococcal Infections: The organism in vivo and in vitro. 1983;2:481
  3. 3. Foster TJ. Potential for vaccination against infections caused by Staphylococcus aureus. Vaccine. 1991;9:221
  4. 4. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcusaureus disease in three communities. The New England Journal of Medicine. 2005;352:1436-1444. DOI: 10.1056/NEJMoa043252
  5. 5. Schlievert PM. Role of superantigens in human disease. The Journal of Infectious Diseases. 1993;167:997
  6. 6. Lyon BR, Skurray R. Antimicrobial resistance in Staphylococcus aureus: Genetic basis. Microbiological Reviews. 1987;51:88
  7. 7. Rammelkamp CH, Maxon T. Resistance of Staphylococcus aureus to the action of penicillin. Experimental Biology and Medicine (Maywood, N.J.). 1942;51:386-389. DOI: 10.3181/00379727-51-13986
  8. 8. Kim HK, Falugi F, Missiakas DM, Schneewinda O. Peptidoglycan-linked protein A promotes T cell-dependent antibody expansion during Staphylococcus aureus infection. Proceedings of the National Academy of Sciences of the United States of America. 2016;113:5718-5723. DOI: 10.1073/pnas.1524267113
  9. 9. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerging Infectious Diseases. 2001;7:178-182. DOI: 10.3201/eid0702.700178
  10. 10. Bennett PM. Plasmid encoded antibiotic resistance: Acquisition and transfer of antibiotic resistance genes in bacteria. British Journal of Pharmacology. 2008;153(Suppl 1):S347-S357
  11. 11. Wertheim HF, Verveer J, Boelens HA, van Belkum A, Verbrugh HA, Vos MC. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrobial Agents and Chemotherapy. 2005;49:1465-1467. DOI: 10.1128/AAC.49.4.1465-1467.2005
  12. 12. Kluytmans J. Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clinical Microbiology Reviews. 1997;10:505-520
  13. 13. Kraemer SA, Ramachandran A, Perron GG. Antibiotic pollution in the environment: From microbial ecology to public policy. Microorganisms. 2019;7:180
  14. 14. Hayashi S, Mitsuko A, Kimoto M, Furukawa S, Nakazawa T. The DsbA-DsbB disulphide bond formation system of Burkholderia cepacia is involved in the production of protease and alkaline phosphatase, motility, metal resistance, and multi-drug resistance. Microbiology and Immunology. 2000;44:41-50
  15. 15. Fuda C, Suvorov M, Vakulenko SB, Mobashery S. The basis for resistance to β-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. Journal of Biological Chemistry. 2004;279:40802-40806. DOI: 10.1074/jbc.M403589200
  16. 16. Foster TJ, McDevitt D. Molecular basis of adherence of staphylococci to biomaterials. In: Bisno AL, Waldvogel FA, editors. Infections Associated with Indwelling Medical Devices. 2nd ed. Washington, D.C.: American Societyfor Microbiology; 1994. p. 31
  17. 17. Licitra G. Etymologia: Staphylococcus. Emerging Infectious Diseases. 2013;19:1553. DOI: 10.3201/eid1909.ET1909
  18. 18. Greenwood D, O’Grady F. Scanning electron microscopy of Staphylococcus aureus exposed to some common anti-staphylococcal agents. Journal of General Microbiology. 1972;70:263-270. DOI: 10.1099/00221287-70-2-263
  19. 19. Foster T. Chapter 12: Staphylococcus. In: Medical Microbiology. 4th ed. Galveston (TX): University of Texas Medical Branch at Galveston, Galveston, Texas; 1996
  20. 20. Touhami A, Jericho MH, Beveridge TJ. Atomic force microscopy of cell growth and divisionin Staphylococcus aureus. Journal of Bacteriology. 2004;186:3286-3295. DOI: 10.1128/JB.186.11.3286-3295.2004
  21. 21. Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clinical Microbiology Reviews. 2015;28:603-661. DOI: 10.1128/CMR.00134-14
  22. 22. Rupp ME, Archer GL. Coagulase-negative staphylococci: Pathogens associated with medical progress. Clinical Infectious Diseases. 1994;19:231
  23. 23. Skinner GRB, Ahmad A. Staphylococcal vaccines—Present status and future prospects. In: Mollby R, Flock JI, Nord CE, Christensson B, editors. Staphylococci and Staphylococcal Infections. Zbl. Bakt. Suppl. 26. Stuttgart: Fischer Verlag; 1994. p. 537
  24. 24. Flores-Tejeida LB, Soto-Zarazua GM, Guevara-Gonzalez R, Escamilla-Garcia A, Gomez-Soto JG. A review of hot and sweet pepper added in animal nutrition: Alternative against the use of antibiotics. XIV International Engineering Congress (CONIIN). 2018;1:1-6. DOI: 10.1109/CONIIN.2018.8489822
  25. 25. Baker-Austin C, Wright MS, Stepanauskas R, McArthur JV. Co-selection of antibiotic and metal resistance. Trends in Microbiology. 2006;14:176-182
  26. 26. Tenover F, Arbeit R, Archer G, et al. Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus. Journal of Clinical Microbiology. 1994;32:407
  27. 27. Vaudaux PE, Lew DP, Waldvogel FA. Host factors predisposing to and influencing therapy of foreign bodyinfections. In: Bisno AL, Waldvogel FA, editors. Infections Associated with Indwelling Medical Devices. 2nd ed. Washington, D.C.: American Society for Microbiology; 1994. p. 1
  28. 28. Archer GL. Staphylococcus aureus: A well-armed pathogen. Clinical Infectious Diseases. 1998;26:1179-1181
  29. 29. Kluytmans JA, Wertheim HF. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection. 2005;33:3-8. DOI: 10.1007/s15010-005-4012-9
  30. 30. Williams REO. Healthy carriage of Staphylococcus aureus: Its prevalence and importance. Bacteriological Review. 1963;27:56-71
  31. 31. Kirby WM. Extraction of highly potent penicillin inactivator from penicillin resistant Staphylocooci. Science. 1942;99:452-453. DOI: 10.1126/science.99.2579.452
  32. 32. Bondi JA, Dietz CC. Penicillin resistant Staphylococci. Proceedings of the Society for Experimental Biology and Medicine. 1945;60:55-58
  33. 33. Lowy FD. Antimicrobial resistance: The example of Staphylococcus aureus. The Journal of Clinical Investigation. 2003;111:1265-1273. DOI: 10.1172/JCI18535
  34. 34. Jevons PM. “Celbenin”—Resistant Staphylococci. British Medical Journal. 1961;1:124-125
  35. 35. Ito T, Kuwahara-Arai K, Katayama Y, Uehara Y, Han X, Kondo Y, Hiramatsu K. Staphylococcal Cassette Chromosome mec (SCCmec) analysis of MRSA. Methods in Molecular Biology 2014;1085:131-148. DOI: 10.1007/978-1-62703-664-1_8
  36. 36. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976-2984. DOI: 10.1001/jama.290.22.2976
  37. 37. Brabban AD, Hite E, Callaway TR. Evolution of foodborne pathogens via temperate bacteriophage-mediated gene transfer. Foodborne Pathogens and Disease. 2005;2:287-303
  38. 38. Chee-Sanford JC, Krapac IJ, Yannarell AC, Mackie RI. Environmental impacts of antibiotic use in the animal production industry. Prevention of Infectious Diseases in Livestock and Wildlife (book published in 2012). In: Ecology and Animal. 2012
  39. 39. Rizzo L, Manaia C, Merlin C, Schwartz T, Dagot C, Ploy MC, et al. Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review. Science of the Total Environment. 2013;447:345-360
  40. 40. Prevost G, Couppie P, Prevost P, et al. Epidemiological data on Staphylococcus aureus strains producingsynergohymenotropic toxins. Journal of Medical Microbiology. 1995;42:237
  41. 41. Hall BG, Barlow M. Evolution of the serine β-lactamases: Past, present and future. Drug Resistance Updates. 2004;7:111-123
  42. 42. Salyers AA, Amábile-Cuevas CF. Why are antibiotic resistance genes so resistant to elimination? Antimicrobial Agents and Chemotherapy. 1997;41:2321-2325
  43. 43. Xiong W, Sun Y, Zhang T. et al. Antibiotics, Antibiotic Resistance Genes, and Bacterial Community Composition in Fresh Water Aquaculture Environment in China. Microb Ecol. 2015;70:425-432.
  44. 44. Anonymous. Antibiotic Fact Sheet: Antibiotic Use in Livestock Production: Ensuring Meat Safety. NW, Washington, D.C.: American Meat Institute; 2010. Available from:
  45. 45. Nielsen KM, Smalla K, van Elsas JD. Natural transformation of Acinetobacter sp. strain BD413 with cell lysates of Acinetobacter sp., Pseudomonas fluorescens, and Burkholderia cepacia in soil microcosms. Applied Environmental Microbiology. 2000;66:206-212

Written By

Muhammad Farooq, Ifra Siddique and Zia Ullah

Submitted: 28 December 2020 Reviewed: 27 August 2021 Published: 08 December 2021